The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

In April, the CDC’s influential Advisory Committee on Immunization Practices recommended expanding RSV vaccination to ...

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...

Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...

The Centers for Disease Control and Prevention's vaccine advisory committee wrapped up the first day of its meeting since ...

RSV vaccine access expanded to some people in their 50s, according to CDC website The decision appears on a CDC webpage but wasn’t on the agency’s official adult immunization schedule.

Merck's Enflonsia vaccine is the second RSV monoclonal antibody that is recommended for approval to prevent RSV. The Food and ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by an advisory panel in April on the ...

The U.S. Centers for Disease Control and Prevention (CDC) has accepted recommendations from an advisory panel that endorsed ...

RSV vaccine access expanded to some people in their 50s, according to CDC website The decision appears on a CDC webpage but wasn’t on the agency’s official adult immunization schedule.